Iceni Glycoscience

Pre-clinical

Cambridge, United StatesFounded 2017iceniglycoscience.com

Focuses on developing glycan-based therapeutics for inflammatory and autoimmune diseases.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $30M

Focuses on developing glycan-based therapeutics for inflammatory and autoimmune diseases.

Diagnostics

Total raised:$30M

Series A$25MRA Capital ManagementMay 15, 2023

Seed$5MUndisclosedMar 15, 2021